Transcription factors that regulate the quiescence, proliferation and homing of lymphocytes are critical for effective immune system function. Here we demonstrate that the transcription factor ELF4 directly activated the tumor suppressor KLF4 'downstream' of T cell antigen receptor signaling to induce cell cycle arrest in naive CD8 + T cells. Elf4-and Klf4-deficient mice accumulated CD8 + CD44 hi T cells during steady-state conditions and generated more memory T cells after immunization. The homeostatic population expansion of CD8 + CD44 hi T cells in Elf4-null mice resulted in a redistribution of cells to nonlymphoid tissue because of lower expression of the transcription factor KLF2 and the surface proteins CCR7 and CD62L. Our work describes the combinatorial effect of lymphocyte-intrinsic factors on the homeostasis, activation and homing of T cells.
Transcription factors that regulate the quiescence, proliferation and homing of lymphocytes are critical for effective immune system function. Here we demonstrate that the transcription factor ELF4 directly activated the tumor suppressor KLF4 'downstream' of T cell antigen receptor signaling to induce cell cycle arrest in naive CD8 + T cells. Elf4-and Klf4-deficient mice accumulated CD8 + CD44 hi T cells during steady-state conditions and generated more memory T cells after immunization. The homeostatic population expansion of CD8 + CD44 hi T cells in Elf4-null mice resulted in a redistribution of cells to nonlymphoid tissue because of lower expression of the transcription factor KLF2 and the surface proteins CCR7 and CD62L. Our work describes the combinatorial effect of lymphocyte-intrinsic factors on the homeostasis, activation and homing of T cells.
A delicate balance between quiescence and homeostatic proliferation maintains the T cell pool. An emerging paradigm suggests that quiescence is an actively regulated state, rather than the default state, in the absence of proliferation-inducing signals 1 . Homeostatic proliferation of CD8 + T cells is an efficient mechanism for maintaining the T cell pool during aging 2 . However, neither the molecular mechanisms that regulate the homeostasis of CD8 + T cell nor the effect of this homeostasis on T cell activation and homing are completely understood. The identification of more negative regulators of T cell proliferation is vital for further understanding of lymphocyte homeostasis and immune responses as well as for the development of protocols of gene modulation to enhance the immunological memory generated after vaccination.
The transcription factor ELF4 (also known as MEF) is a member of the Ets family of proteins [3] [4] [5] . Reports suggest that ELF4 can function as a tumor suppressor in hematopoietic cells. ELF4 expression is downregulated in acute myelogenous leukemia, either by oncoproteins or by chromosome translocation with ERG (which encodes the transcriptional regulator ERG) [6] [7] [8] . Studies of ELF4-deficient mice have shown that ELF4 induces a state of readiness in natural killer cells by activating expression of the gene encoding perforin 3, 9 . Moreover, ELF4 controls the balance between activation and quiescence in hematopoietic stem cells during steady-state conditions but not during regenerative hematopoiesis 10 . Therefore, we hypothesized that ELF4 may regulate the entry of T cells into the cell cycle by activating an inhibitor of proliferation.
Krüppel-like factor 4 (KLF4) is a zinc-finger transcriptional regulator that acts as a tumor suppressor and oncogene in the gastrointestinal tract and breast tissue, respectively [11] [12] [13] . In the hematopoietic system, KLF4 is silenced in patients with adult T cell leukemia 14 . The finding that KLF4 can 'reprogram' adult somatic cells into pluripotent stem cells in combination with transcription factors Sox2 and Oct3-Oct4 and the proto-oncogene product c-Myc suggests involvement of this transcription factor in the prevention of cellular proliferation and differentiation [15] [16] [17] . KLF2 (A004085) was the first transcription factor described as being able to 'program' T cell quiescence by inhibiting the c-Myc pathway 18 . Other cell-intrinsic inhibitors of T cell proliferation include the Foxo transcription factors, the antiproliferative protein Tob, dipeptidyl peptidase 2 and the transcription factor NFAT2c [19] [20] [21] [22] . Gene products involved in controlling the cell cycle can also influence the number of antigen-experienced memory CD8 + T cells generated at the end of an immune response [23] [24] [25] [26] . In addition, the transcription factor T-bet promotes the differentiation of effector T cells over that of memory precursor cells, whereas the basic helix-loop-helix protein Id2 regulates the survival of effector T cells via the proteinase inhibitor Spi6 (refs. [27] [28] [29] .
Memory-like T cells are generated during lymphopenia-or cytokine-induced homeostatic proliferation of naive T cells 2, 30 . A similar gene-expression profile and the same cell of origin suggest that antigen-experienced and memory-like T cells use common mechanisms to control proliferation 31 . Gene products that influence T cell proliferation can also regulate homing receptors and thereby direct T cell trafficking. In contrast to CD62L lo CCR7effector memory T cells (T EM cells), which home to nonlymphoid tissues and the spleen, CD62L hi CCR7 + central memory T cells (T CM cells) home to the lymph nodes 32, 33 . KLF2 promotes the circulation of naive T cells through the lymphoid organs by regulating expression of the lymph node-homing receptor CD62L (L-selectin), sphingosine 1-phosphate receptor type 1, the chemokine receptor CCR7 and b 7 integrin 34, 35 . Conversely, the suppression of KLF2 expression induced by stimulation of the T cell antigen receptor (TCR) results in the mobilization of effector T cells to inflamed tissues because KLF2 represses expression of the CCR3 and CCR5 chemokine receptors 36 . Although the function of KLF2 has been established in naive T cells, it has not been defined in memory T cells or in the maintenance of the size of the T cell pool. Neither the transcriptional mechanisms controlling the homeostatic and antigen-driven proliferation of naive T cells and the differentiation of naive T cells into memory T cells nor the lineage relationships among memory T cell subsets have been identified, despite the importance of these mechanisms in vaccination and immune protection.
Here we demonstrate that ELF4 regulates the proliferation of naive CD8 + T cells and the tissue distribution of CD8 + CD44 hi T cells. ELF4 activated KLF4 'downstream' of TCR signaling to induce cell cycle arrest in naive CD8 + T cells. Naive CD8 + T cells from mice lacking ELF4 or KLF4 were primed to proliferate during homeostasis or after immunization because of accumulation of cyclin D in the cytosol and repression of cyclin-dependent kinase inhibitors. In addition, in ELF4-deficient mice, CD8 + CD44 hi T cell populations gradually accumulated and redistributed to nonlymphoid tissues because of lower expression of KLF2, CCR7 and CD62L. Thus, in addition to KLF2, the tumor suppressors ELF4 and KLF4 regulate the proliferation and homing of T cells.
RESULTS

ELF4 suppresses homeostatic and antigen-driven proliferation
To determine whether ELF4 regulates the entry of naive CD8 + T cells into the cell cycle as it does that of hematopoietic stem cells, we measured proliferation in response to homeostatic and antigen-driven stimuli. We used two systems to test the homeostatic proliferation of Elf4 -/-CD8 + T cells: in vivo incorporation of the thymidine analog BrdU and adoptive transfer of naive CD8 + T cells into lymphopenic hosts. Although administration of BrdU showed a low rate of T cell proliferation, activated Elf4 -/-CD8 + CD44 hi T cells incorporated significantly more BrdU than did Elf4 +/+ CD8 + CD44 hi T cells ( Fig. 1a ). Next we purified CD8 + CD44 lo CD45.2 + T cells from Elf4 +/+ and Elf4 -/mice, labeled them with the cytosolic dye CFSE and adoptively transferred them into sublethally irradiated B6.SJL mice to induce homeostatic proliferation. At least 80% of the transferred Elf4 -/-CD8 + T cells underwent more than five divisions, compared with only 17% of the Elf4 +/+ CD8 + T cells ( Fig. 1b) . Furthermore, the Elf4 -/naive CD8 + T cells 'out-competed' the Elf4 +/+ CD8 + T cells when we injected the two populations together into irradiated B6.SJL mice ( Supplementary Fig. 1 online). To determine whether the self-renewal of memory-like T cells was also greater, we purified CD8 + CD44 lo and CD8 + CD44 hi T cells and measured their proliferation in vitro. Interleukin 15 (IL-15) induced similar proliferation of Elf4 +/+ and Elf4 -/-CD8 + CD44 hi T cells ( Fig. 1c) . In contrast, CD8 + CD44 lo T cells isolated from Elf4 -/mice proliferated more than did Elf4 +/+ CD8 + CD44 lo cells in response to TCR activation ( Fig. 1c ).
We obtained similar results when we adoptively transferred Elf4 +/+ OT-I CD8 + CD44 lo T cells or Elf4 -/-OT-I CD8 + CD44 lo T cells and activated them in vivo by intravenous administration of a peptide of ovalbumin amino acids 257-264 (OVA(257-264); Fig. 1d ). This readiness to proliferate suggested a lower threshold of activation. In support of that hypothesis, Elf4 -/-OT-I CD8 + T cells underwent more proliferation than did Elf4 +/+ OT-I CD8 + T cells in response to low concentrations of OVA(257-264) in vitro ( Fig. 1e ).
Aberrant expression of factors that facilitate the transition from G1 phase to S phase can prime T cells to proliferate rapidly after activation. TCR crosslinking induced faster phosphorylation of retinoblastoma protein (Rb) in Elf4 -/-CD8 + T cells than in Elf4 +/+ CD8 + T cells ( Fig. 1f) . Additionally, the expression of cyclins D1, D3 and E was higher, whereas the expression of the cell cycle inhibitors p21, p15 and p27 was lower, in Elf4 -/-CD8 + T cells than in Elf4 +/+ CD8 + T cells ( Fig. 1g ). Those findings, together with the accumulation of cyclins D1 and D3 in the cytosol of Elf4 -/-CD8 + T cells, were consistent with the idea that Elf4 -/-CD8 + T cells exist in a late G1 stage ( Fig. 1h ). Although we did not detect substantial phosphorylated Rb in unstimulated Elf4 -/-CD8 + T cells, the BrdU-incorporation experiments suggested a higher steady-state proliferation rate of this population ( Fig. 1a) . On the basis of the data presented above, we propose that ELF4 negatively regulates proliferation of naive CD8 + T cells by raising the activation threshold. Therefore, we investigated the effect of Elf4 deletion on the generation of memory-like and antigenexperienced memory T cells during homeostasis and antigen-driven presentation, respectively.
ELF4 regulates the quiescence of naive T cells
The homeostatic proliferation of naive T cells contributes to the maintenance of the T cell pool, especially as thymic production wanes during aging, leading to the accumulation of T cells with a memory-like phenotype 30, 37, 38 . These memory-like CD8 + CD44 hi CD122 + T cells are detected even in mice kept in a pathogen-free environment. The percentage of CD44 hi CD122 + cells in the CD8 + T cell pool gradually increased with age to represent 30-40% of CD8 + T cells in the spleens of wild-type mice (Fig. 2a) . The expansion of the CD8 + CD44 hi CD122 + T cell population was significantly accelerated in Elf4 -/mice, such that up to 70% of the total CD8 + T cell compartment in 13-month-old mice was CD44 hi CD122 + (Fig. 2a ). That accumulation correlated with a decrease in the number of naive CD8 + CD44 lo T cells, which suggests that CD8 + T cells in Elf4 -/mice are spontaneously activated. In addition, Elf4 -/mice showed splenomegaly and hyperplasia of the white pulp, accumulation of CD4 + and CD8 + T cells in the spleen, and lymphocytic infiltration of the liver with age ( Supplementary Fig. 2 online). To determine whether this T cell population expansion was due to T cell-intrinsic factors, we generated bone marrow chimeras with green fluorescent protein-positive (GFP + ) Elf4 +/+ or Elf4 -/bone marrow cells as the donor cells and wild-type mice as recipients. The percentage of CD44 hi CD122 + cells in the CD8 + T cell pool derived from Elf4 -/donor cells increased over time at a rate significantly greater than that of Elf4 +/+ donor cells ( Fig. 2b) , which suggests that the accelerated expansion of Elf4 -/-T cell populations is T cell intrinsic and is not due to an altered environment in Elf4 -/mice. 
Cells Cells Outgrowth of autoreactive T cell clones could potentially account for the T cell population expansion in Elf4 -/mice. However, we noted a similar distribution of TCR variable region b-chains on CD8 + CD44 hi T cells in Elf4 -/mice and age-matched Elf4 +/+ control mice ( Supplementary Fig. 3a online), which suggests that the T cell population was polyclonal rather than oligoclonal. We also examined the homeostatic expansion of Elf4 -/-T cell populations specific for a foreign antigen by crossing Elf4 -/mice with OT-I-transgenic mice. Elf4 -/-OT-I mice accumulated CD8 + CD44 hi CD122 + T cells at a rate and to an extent similar to those of Elf4 -/mice ( Supplementary  Fig. 3b ). In addition, whereas the majority (77%) of CD8 + CD44 hi CD122 + T cells in Elf4 -/-OT-I mice stained with the H2-K b -OVA(257-264) tetramer, only 16% of CD8 + CD44 hi CD122 + T cells in Elf4 +/+ OT-I mice bound this tetramer. Therefore, ELF4 regulates T cell homeostasis, and Elf4 -/mice show polyclonal T cell population expansion due to T cell-intrinsic defects.
ELF4 regulates the expression of KLF2
Next we analyzed T cell distribution in different tissues of older Elf4 +/+ and Elf4 -/mice, because a continuously expanding T cell pool could induce a redistribution of T cells. In 13-month-old Elf4 -/mice, CD8 + CD44 hi T cells accumulated in the spleen, blood, liver, lung and bone marrow but not in the lymph nodes ( Fig. 3a) . Even though there was no accumulation of cells in the lymph nodes, the presence of some Elf4 -/memory-like T cells in this tissue could have been due to entry through afferent lymphatics. Next we examined the cell surface expression of CD62L, an indicator of lymph node-homing potential, on Elf4 -/-CD8 + T cells (Fig. 3b) . Although we found similar CD62L expression on CD8 + CD44 lo T cells from 3-month and 13-month-old Elf4 +/+ and Elf4 -/mice, the expression of CD62L was substantially downregulated on CD8 + CD44 hi T cells from 13-month-old Elf4 -/mice ( Fig. 3b ). This downregulation of CD62L was a gradual process that correlated with T cell population expansion (Supplementary Fig. 4a online). CCR7 was also downregulated on CD8 + CD44 hi T cells from 13-month-old Elf4 -/mice ( Supplementary  Fig. 5 online) . The population expansion of CD44 hi T cells in Elf4 -/mice was not exclusive to CD8 + T cells; CD4 + CD44 hi T cells also accumulated and lost expression of CD62L and CCR7 over time ( Supplementary Fig. 6 online). Loss of expression of CD62L and CCR7 on CD8 + CD44 hi T cells suggests an age-dependent conversion from the T CM phenotype to the T EM phenotype. To evaluate the relationship between these subsets, we tracked the cell fate of adoptively transferred memory T cell populations from Elf4 +/+ and Elf4 -/mice. T EM cells purified from Elf4 +/+ and Elf4 -/mice did not acquire much CD62L expression after adoptive transfer ( Fig. 3c ). However, unlike Elf4 +/+ T CM cells, approximately 80% of the Elf4 -/-T CM cells lost CD62L from the cell surface by 35 d after adoptive transfer (Fig. 3c) .
The homeostatic expansion of CD8 + T cell populations in Elf4 -/mice led to the continuous accumulation of CD8 + CD44 hi CD62L lo T cells, which suggests that ELF4 may regulate the expression of inducers of CD62L expression. Thus, we examined expression of KLF2, the main activator of CD62L expression in naive T cells, in Elf4 -/-CD8 + T cells 34, 35 . The expression of CD62L and KLF2 mRNA and protein was lower in CD8 + T cells isolated from 13-month-old Elf4 -/mice ( Fig. 4a ). To confirm that this effect was due to ELF4, we crossed Elf4 -/mice with Vav-ELF4-transgenic mice to restore ELF4 activity in the hematopoietic system. As predicted, ectopic expression of ELF4 restored CD62L expression on the surface of CD8 + CD44 hi T cells of 13-month-old Elf4 -/mice ( Fig. 4b) . CD8 + CD44 hi T cells from 13-month-old Elf4 -/mice had less CD62L mRNA; this was prevented by transgenic expression of ELF4 ( Fig. 4c ). Even though ELF4 was able to activate the Klf2 promoter in vitro ( Supplementary  Fig. 4b ), we did not detect ELF4 bound to the Klf2 regulatory sequences in CD8 + T cells isolated from 13-month-old Elf4 +/+ mice ( Fig. 4d ). However, chromatin-immunoprecipitation analysis showed that KLF2, but not ELF4, bound to the promoter of the gene encoding CD62L (Sell) in Elf4 +/+ but not Elf4 -/-CD8 + T cells ( Fig. 4d ). Of note, there was normal expression of Foxo1, another activator of CD62L and CCR7 in naive T cells 39 , in Elf4 -/-CD8 + CD44 hi T cells (data not shown). Collectively, these results suggest that the homeostatic expansion of CD8 + T cell populations with a memory-like phenotype results in downregulation of CD62L and CCR7, which diverts the excess CD8 + CD44 hi T cells from the lymph nodes to the spleen and nonlymphoid tissues.
ELF4 restricts memory after vaccination
Cell cycle regulation is critical in the clonal expansion of antigenspecific naive T cell populations during infection or vaccination. To assess whether ELF4 also regulates proliferation after priming, we used dendritic cells (DCs) pulsed with OVA(257-264) to immunize B6.SJL mice that had been given adoptive transfer 24 h earlier of CD8 + T cells isolated from OVA-specific Elf4 +/+ or Elf4 -/-OT-I mice. Staining with the H-2K b -OVA(257-264) tetramer showed there was a significantly higher proportion and number of Elf4 -/than Elf4 +/+ OVA-specific CD8 + T cells at the peak of expansion (day 4) and at day 40 ( Fig. 5a and Supplementary Fig. 7 online) . To rule out the possibility of microenvironmental effects, we transferred a 1:1 mixture of Elf4 +/+ and Elf4 -/-OT-I CD8 + T cells into B6.SJL recipients. Elf4 +/+ CD8 + T cells were 'out-competed' by Elf4 -/-CD8 + T cells after immunization in the same environment (Fig. 5b) .
Our data suggested that the naive Elf4 -/-CD8 + T cell populations did not exhaust memory precursor cells during the differentiation to effector T cells. Even though the distribution of short-lived effector cells and memory precursor cells did not differ significantly among Elf4 +/+ versus Elf4 -/donor-derived CD8 + T cells, the overall expansion of both subsets was greater for Elf4 -/-CD8 + T cells (Fig. 5c) . A caveat to this is that not all memory precursor cells identified in this way become memory T cells after vaccination with DCs 40, 41 . Despite that limitation, our findings about the accumulation of memory precursor cells was consistent with the greater number of tetramerpositive CD8 + T cells detected at late time points after vaccination. We next did in vivo cytolytic assays to evaluate whether Elf4 -/memory CD8 + T cells generated after vaccination were able to recognize and lyse antigen-bearing target cells (CFSE bright OVA-pulsed splenocytes). OVA-specific memory CD8 + T cells generated from Elf4 -/-OT-I CD8 + T cells more efficiently lysed antigen-bearing target cells in vivo than did those from Elf4 +/+ OT-I cells (Fig. 5d ). However, we did not analyze these results on a 'per-cell' basis; thus, the apparent greater specific lysis by Elf4 -/memory T cells was due to their greater frequency in the spleen. Therefore, our data indicate that ELF4 negatively regulates the clonal proliferation of naive CD8 + T cells and the generation of functional memory T cells after immunization.
KLF4 inhibits the proliferation of CD8 + T cells
We hypothesized that ELF4 most likely activates the expression of an inhibitor of proliferation, because ELF4 does not have any known direct involvement in the progression of the cell cycle. In an effort to identify target genes of ELF4, we did global gene-expression analysis with RNA isolated from resting and in vitro-activated CD8 + T cells. Most of the differences we detected in Elf4 +/+ and Elf4 -/-CD8 + T cells were in the unactivated populations (Fig. 6a) . Naive Elf4 -/-CD8 + T cells had higher expression of factors that promote passage through the transition from G1 phase to S phase and lower expression of factors that inhibit cell cycle progression ( Supplementary Fig. 8 online) . In addition, KLF4 expression was substantially downregulated in Elf4 -/-CD8 + T cells. We next further investigated KLF4, given its homology to KLF2 and its dual function as tumor suppressor and oncogene 11, 42 . If ELF4 negatively regulates T cell proliferation by directly inducing expression of KLF4, this ELF4-mediated suppression of proliferation must be blocked during T cell activation. In agreement with that hypothesis, expression of ELF4 and KLF2 decreased immediately after TCR activation, whereas expression of KLF4 decreased 16-20 h later (Fig. 6b) . In further support of this model, the expression of KLF4 and p21 was inversely correlated with the extent of proliferation of CD8 + T cells from Elf4 -/and Elf4 -/-Vav-ELF4 mice (Fig. 7a) . Ectopic expression of ELF4 restored the expression of KLF4 and p21 and normalized the proliferation of Elf4 -/-CD8 + T cells by increasing the percentage of nonproliferative T cells (Fig. 7b) . That finding suggests that the hyperproliferation of Elf4 -/-CD8 + T cells was due to defective expression of KLF4 and p21 (Fig. 7a) . Reporter assays demonstrated that Klf4 transcription was induced by ELF4, as well as by the known activator Sp1 (ref. 43 ; Fig. 7c ). To further confirm the direct regulation of Klf4 by ELF4 in vivo, we did chromatin-immunoprecipitation assays to evaluate Klf4 promoter occupancy. We detected Klf4 regulatory sequences by PCR with primers spanning the Klf4 promoter in DNA immunoprecipitated with antibody to ELF4 (anti-ELF4; Fig. 7d ). These data indicate that KLF4 maintains T cell quiescence 'downstream' of ELF4, perhaps by directly activating p21 expression in CD8 + T cells. To directly assess the influence of KLF4 on T cell proliferation, we generated Klf4-deficient mice to test the effect of KLF4 on T cell proliferation. We crossed mice with loxP-flanked Klf4 alleles (Klf4 fl/fl ) with mice transgenic for expression of Cre recombinase driven by the promoter of the gene encoding the myxovirus-resistance 1 polypeptide (Mx1-Cre) to induce deletion of Klf4 in adult mice with polyinosinicpolycytidylic acid (poly(I:C)). We confirmed the efficacy of Klf4 deletion by PCR analysis of genomic DNA isolated from purified CD8 + T cells (Fig. 7e) . We did not use Klf4 fl/+ Mx1-Cre + mice as controls because heterozygosity for Elf4 leads to the population expansion of CD8 + CD44 hi CD122 + T cells ( Supplementary Fig. 9 online). We indirectly evaluated the effect of transient Cre expression on T cell population expansion with CD8 + T cells from CD4-Cretransgenic mice ( Supplementary Fig. 9 ). In vitro TCR crosslinking experiments showed that CD8 + T cells from Klf4-deficient mice (Klf4 fl/fl Mx1-Cre + mice treated with poly(I:C)) proliferated more than did those from the Klf4 fl/fl control mice (Klf4 fl/fl Mx1-Cre À mice treated with poly(I:C) Fig. 7e ). Furthermore, Klf4-deficient mice had more homeostatic population expansion of CD8 + CD44 + T cells in the spleen, similar to that in older Elf4 -/mice (Fig. 7f) . Our data collectively indicate that circulating CD8 + T cells remain quiescent because of the coordinated expression of ELF4 and KLF4 and that TCR activation disrupts this inhibition of proliferation by repressing ELF4 expression.
DISCUSSION
Here we have demonstrated that ELF4 controls homeostatic and antigen-driven T cell proliferation and T cell homing by inducing expression of KLF4 and T cell homing via KLF2. ELF4 transactivated the tumor suppressor KLF4 in naive CD8 + T cells, which is needed to maintain the quiescent state. Loss of ELF4 led to deregulated T cell population expansion during homeostasis and after immunization, probably because of enrichment of factors promoting progression through the transition from G1 phase to S phase. Similarly, deletion of Klf4 resulted in more homeostatic expansion of CD8 + CD44 hi T cell populations and deregulated proliferation of CD8 + CD44 lo T cells after activation. This inhibition of proliferation was disrupted after T cell activation by inhibition of Elf4 and Klf4. In addition, we noted a progressive shift in the tissue distribution of CD8 + CD44 hi T cells due to loss of the expression of KLF2, CCR7 and CD62L; KLF2-deficient cells homed to nonlymphoid tissues, presumably to accommodate a growing pool of memory-like T cells.
Our work suggests that KLF4 is a negative regulator of the proliferation of naive CD8 + T cells 'downstream' of ELF4. These intrinsic regulatory factors not only prevent homeostatic proliferation in response to weak self major histocompatibility complex signals but also prevent the clonal expansion of naive CD8 + T cells and generation of immunological memory. Adoptive transfer experiments have shown that ELF4-dependent homeostatic population expansion of CD8 + T cells is independent of environmental factors, some of which (for example, IL-7 and IL-15) are important extrinsic regulators of homeostatic T cell proliferation 2 . The enhanced antigen-driven proliferation of Elf4 -/-CD8 + T cells was also cell autonomous, as immunization of recipients of both Elf4 -/and Elf4 +/+ OT-I CD8 + T cells resulted in 'out-competition' of Elf4 +/+ OT-I CD8 + T cells by Elf4 -/-OT-I CD8 + T cells in the same environment.
In addition to regulating CD4 + and CD8 + T cells, ELF4 regulates the proliferation of B cells 9 , ovarian epithelial cancer cell lines 44 and hematopoietic stem cells 10 . ELF4 and c-Myb are the only known negative regulators of hematopoietic stem cell quiescence during homeostasis 10, 45 . In contrast to hematopoietic stem cells, Elf4 -/naive T cells remain in the late G1 stage, poised to proliferate. We have shown that KLF4 was directly regulated by ELF4 and that KLF4 expression correlated with expression of the cell cycle inhibitor p21 in naive T cells. Notably, the 'preactivated' state of Elf4 -/-CD8 + T cells is reminiscent of memory T cells 46 . There are no reports to our knowledge describing involvement of KLF4 in T cell proliferation, although Klf4 has been shown to suppress B cell proliferation as a target of the Foxo transcription factor 47 .
Reports have identified cell surface molecules required for the trafficking of naive T cells to the lymph nodes and inflamed tissues [34] [35] [36] 48 . However, although KLF2 is the best known trafficking controller in naive T cells, the function of KLF2 in tissue homing and the relationship among different subsets of memory T cells has remained unknown. Deletion of Elf4 led to the loss of the expression of KLF2, CCR7 and CD62L in CD8 + CD44 hi T cells. We found that even though KLF2 regulated CD62L in CD8 + T cells, ELF4 did not activate KLF2 expression despite its ability to activate the Klf2 promoter in vitro. The functions of molecules encoded by genes activated by Ets proteins in vitro often do not correlate with their functions in vivo because of cell-specific transcriptional machinery and functional redundancy. Therefore, the greater homeostatic proliferation of CD8 + T cells triggers downregulation of KLF2 and accumulation of CD8 + CD44 hi CD62L lo T cells, presumably to prevent lymph node swelling. In fact, it has been shown that exacerbated expansion of memory CD8 + T cell populations results in more CD8 + CD44 hi CD62L lo T cells in the spleen and nonlymphoid tissues but not in the lymph nodes 49 . Notably, loss of CD62L expression has been detected in T lymphocytes from elderly humans, and therefore deletion of Elf4 may accelerate the normal process of aging in the immune system 50 . The signals that regulate the size of the CD8 + T cell pool in the lymph nodes are mostly unknown, although data presented here support the argument that ELF4 prevents CD8 + T cells from reaching the size limit of the T cell pool. Our findings also support the hypothesis that the size of the CD8 + T cell pool is flexible rather than invariable, as thought before 49 . Our findings also raise the issue of whether ELF4 regulates the relationship between T CM and T EM cells and the retention of T CM cells in the lymph nodes. However, it is possible that this apparent conversion of T CM into T EM cells actually represents T CM cells that have lost expression of CD62L and CCR7 but have retained all other features of T CM cells.
In summary, our study has identified two important functions for ELF4. First, ELF4 acts as a negative regulator of naive CD8 + T cell proliferation by directly activating expression of Klf4. Second, by inducing that expression, ELF4 maintains the expression of CD62L and CCR7 on memory T cells. In this way, ELF4 regulates the proliferation of naive T cells and the homing of memory T cells to the lymph nodes. A detailed map of the transcriptional 'machinery' involved in the generation of antigen-specific memory CD8 + T cells will aid in improving long-lasting immune protection. Hence, modulation of the expression of ELF4 or KLF4 could be used in the future to heighten immune response and immunological memory by augmenting the clonal expansion of antigen-specific cells without promoting their terminal differentiation into effector T cells.
METHODS
Methods and any associated references are available in the online version of the paper at http://www.nature.com/natureimmunology/.
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ONLINE METHODS
Mice. Elf4 -/and Vav-ELF4 mice were from S. Nimer and were backcrossed for more than 12 generations to the C57BL/6 background. Klf4 fl/+ mice were from K. Kaestner 51 . C57BL/6, B6.SJL, OT-I TCR-transgenic and GFP-transgenic mice were from Jackson Laboratories. CD4-Cre mice were from T. Tan. Klf4 fl/fl mice were crossed with Mx1-Cre-transgenic mice (Jackson Laboratories) to induce deletion. OT-I-and GFP-transgenic mice were crossed with Elf4 -/mice to generate Elf4 -/-OT-I mice and GFP + Elf4 -/mice, respectively. For adoptive transfer, C57BL/6 mice were crossed with B6.SJL mice to generate Elf4 +/+ CD45.1 + CD45.2 + mice. Mice were irradiated with a Gammacell 40 Exactor irradiator (Nordion) for bone marrow transplantation (9.5 Gy) or to induce lymphopenia (4.5 Gy). All mice were bred and maintained in specific pathogen-free conditions at the Baylor College of Medicine. All experiments were with the approval of the Institutional Animal Care and Usage Committee of Baylor College of Medicine.
Flow cytometry. The following antibodies were used: phycoerythrinanti-CD44 (IM7), phycoerythrin-anti-CD45.1 (A20), fluorescein isothiocyanate-anti-CD45.2 (104), fluorescein isothiocyanate-anti-CD122 (TM-b1), allophycocyanin-anti-CD8 (53-6.7), biotin-anti-KLRG1 (2F1), phycoerythrinanti-CD127 (SB/199) and allophycocyanin-anti-CD62L (MEL-14). All antibodies and streptavidin-allophycocyanin were from BD Biosciences. A fusion of the chemokine CCL19 and the Fc fragment (14-1972-63) , plus phycoerythrin-labeled anti-human IgG Fcg fragment (12-4998-82), were used for CCR7 staining (eBioscience). The TCR variable b-chain repertoire was analyzed with a panel of mouse TCR variable b-chain-specific antibodies (557004; BD Biosciences). Phycoerythrin-labeled H2-K b -OVA(257-264) tetramer was from the MHC Tetramer Core Laboratory (Baylor College of Medicine). Samples were analyzed by flow cytometry with a FACSCanto (BD Biosciences) and FlowJo software (TreeStar). Dilution of CFSE (carboxyfluorescein diacetate succinimidyl ester) was analyzed with ModFit software (Verity).
Purification of CD8 + T cells. CD8 + T cells were purified from spleen with the negative selection BD-IMag magnetic-bead separation system according to the manufacturer's instructions (BD Biosciences). Purified CD8 + T cells were stained with phycoerythrin-labeled anti-CD44 for the purification of CD8 + CD44 hi (memory-like) and CD8 + CD44 lo (naive) T cells with a MoFlo cell sorter (Cytomation).
Adoptive transfer. CD8 + CD44 hi CD62L + and CD8 + CD44 hi CD62L -T cells were purified by cell sorting from CD45.2 + mice. Purified cells (1 Â 10 4 ) were adoptively transferred into unirradiated B6.SJL mice (CD45.1 + ). Cell fate was analyzed 35 d later on the basis of CD62L expression on donor-derived T cells (CD45.2 + ).
T cell proliferation. CD8 + T cells isolated from spleen were labeled for 10 min at 37 1C with 4 mM CFSE (Invitrogen) in PBS with 0.1% (wt/vol) BSA. CFSE was removed by washing of cells with ice-cold RPMI medium containing 10% (vol/vol) FBS. For in vitro stimulation, CD8 + CD44 lo T cells were isolated from 3-month-old mice, labeled with CFSE and cultured for 3 d at density of 1 Â 10 5 cells per well in RPMI medium containing 10% (vol/vol) FBS and 5% (vol/vol) T-Stim (BD Biosciences) in 96-well plates coated with anti-CD3 (Bio-Coat; 754720; BD Biosciences) in the presence of anti-CD28 (2 mg/ml; 37.51; BD Biosciences). CD8 + CD44 hi T cells were stimulated for 7 d with recombinant mouse IL-15 (20 ng/ml; R&D Systems). For in vivo stimulation, 5 Â 10 6 CFSElabeled CD8 + T cells from 3-month-old Elf4 +/+ or Elf4 -/-OT-I mice (CD45.2 + ) were adoptively transferred intravenously into recipient B6.SJL (CD45.1 + ) mice, followed by activation with 50 ng OVA(257-264) (SIINFEKL; ANASpec) the next day. CFSE dilution was assessed by flow cytometry after 3 d of activation. For evaluation of the homeostatic proliferation of naive T cells in lymphopenic hosts, CD8 + CD44 lo T cells (2 Â 10 6 ) from young CD45.2 + Elf4 +/+ or CD45.2 + Elf4 -/mice were labeled with CFSE and transferred into lymphopenic B6.SJL (CD45.1 + ) mice (irradiated with 4.5 Gy). After 9 d, CFSE dilution was measured in donor-derived cells (CD45.2 + ) in the spleen. For in vitro stimulation with OVA(257-264), splenocytes from B6.SJL mice were pulsed for 1 h at 37 1C with various concentrations of OVA(257-264). CFSE-labeled OT-I CD8 + T cells were then stimulated with OVA(257-264)-pulsed splenocytes. CFSE dilution in CD45.2 + cells was analyzed by flow cytometry 3 d later.
Percentage of proliferation was calculated relative to the maximum proliferation induced by OVA(257-264) at a concentration of 1,000 ng/ml.
Immunization with peptide-pulsed DCs. DCs were generated from bone marrow cells cultured with mouse granulocyte-macrophage colony-stimulating factor (10 ng/ml; Peprotech). Media was partially replaced with fresh medium every 2 d and nonadherent cells were transferred to new plates on day 6. DCs were activated for 18 h with LPS (100 ng/ml; Sigma) and activation (CD11c + CD11b + major histocompatibility complex class II-high phenotype) was confirmed by flow cytometry. Finally, DCs were pulsed for 1 h at 37 1C with OVA(257-264) (5 mg/ml) and were washed twice with PBS. CD8 + T cells were purified from Elf4 +/+ and Elf4 -/-OT-I mice and were adoptively transferred into B6.SJL mice (1 Â 10 5 cells per mouse). Then, 24 h later, mice were immunized with 1 Â 10 6 peptide-pulsed DCs. Population expansion of CD8 + T cells in spleen was monitored at various times after immunization by flow cytometry with allophycocyanin-anti-CD8, fluorescein isothiocyanateanti-CD45.2 and phycoerythrin-labeled H2-K b -OVA(257-264) tetramer.
In vivo cytotoxicity assay. The in vivo killing assay was done as described 52 . Splenocytes were labeled with two concentrations of CFSE (2 mM or 8 mM) to generate dim and bright populations. For target cell generation, CFSE bright cells were pulsed for 1 h at 37 1C with OVA(257-264) (5 mg/ml) and were washed twice by the addition of a tenfold volume of PBS. The CFSE dim population was not pulsed with OVA(257-264). A mixture of CFSE dim cells (5 Â 10 6 ) and CFSE bright cells (5 Â Isolation of lymphocytes from liver and lung. Livers and lungs were perfused after dissection by injection of 5-10 ml ice-cold PBS into the hepatic artery or lung ventricle, respectively. Both tissues were homogenized in PBS with a pestle motor mixer (VWR). After being washed with PBS, homogenized tissues were incubated for 45-60 min at 37 1C in RPMI medium containing 5% (vol/vol) FBS, collagenase IV (0.5 mg/ml; Sigma-Aldrich) and DNase I (1.5 U/ml; Qiagen). Then digested tissues were applied to a Ficoll type 40 layer (Sigma-Aldrich) and were centrifuged for 20 min at 741g and 20 1C. Lymphocytes were collected from the interface.
Bone marrow transplantation. Bone marrow cells were extracted from femurs and tibias and were placed in DMEM (Lonza) with 2% (vol/vol) FBS. Cell suspensions were filtered through 40-mm cell strainers (BD Falcon). Bone marrow cells (5 Â 10 6 ) were injected intravenously into the lateral tail veins of recipient mice previously irradiated (4.5 Gy).
Immunoblot analysis. CD8 + T cells were lysed directly with LDS Sample Buffer (Invitrogen) at a density of 1 Â 10 4 cells per ml and were sonicated to shear DNA. An aliquot (10 ml) of the cell lysate was loaded onto NuPAGE Bis-Tris gels (Invitrogen) and proteins were transferred to polyvinylidene difluoride membranes. Proteins were detected with rabbit polyclonal anti-KLF2 (ARP37859-T100; Aviva Systems Biology) and anti-actin (A5060; Sigma-Aldrich). For analysis of cell cycle regulators, rabbit polyclonal anti-cyclin E, (14-6714), anti-cyclin A (14-6711) and anti-p21 (14-6715 all from eBioscience), and rabbit polyclonal anti-p27 (2552) and mouse anti-cyclin D1 (2926), anti-cyclin D3 (2936) and anti-CDK4 (2906; all from Cell Signaling Technology) were used. For analysis of Rb phosphorylation, CD8 + T cells were activated in anti-CD3-coated plates with soluble anti-CD28 and lysates were analyzed with rabbit polyclonal antibody to phosphorylated Rb (Cell Signaling Technology). Goat anti-rabbit IgG and goat anti-mouse IgG conjugated to peroxidase (Pierce) were used as secondary antibodies. X-ray films were developed with an immunoblot detection reagent (Westdura).
Quantitative real-time PCR. Total RNA was extracted from CD8 + T cells with an RNeasy Mini kit (Qiagen). Then, cDNA was syntyhesized from 100-500 ng RNA with random hexamer primers and a SuperScript III kit (Invitrogen). LightCycler FastStart DNA Master SYBR Green I was used for quantitative realtime PCR as specified by the manufacturer (Roche). Primer sequences for PCR
